A New Age in Pricing

Medicines are the preferred path to arrest disease and restore health. And while scientists ...

Say Goodbye to FDA Complacency

Too many people think the Food and Drug Administration (FDA) favors predictability over speed. ...

The Art of Indecision

Caution: We are entering a climate of uncertainty, where the natural response is a ...

Off-label Guidance Finally Arrives

In January, the FDA released its long-anticipated draft guidance, regarding promotion of a medication’s ...

Live from Facebook! It’s Your Friendly Pharma Company

“Live.” It’s a word that can send a shudder through any pharma marketer, but ...

What I Learned from LISTENING to Reporters

Bernard M. Baruch, famed financier, political consultant, and philanthropist, once noted, “Most of the ...

Which Comes First: Trust or User Experience?

For anyone who has been a patient—or cared for one—finding trustworthy information online is ...

If Science Can Evolve, Why Can’t, or Isn’t, Pharma Marketing?

While new treatments focusing on personalized medicine, biosimilars, and targeting specific proteins have come ...

Media Firestorm Surrounds Oncology Communications

For decades now, the price of prescription drugs has been the subject of heated ...

Reaffirmed ACA Shifts Business as Usual

Regardless of how health executives called the recent King v. Burwell coin toss, the ...